rs991967

Variant summary

Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_003238.6(TGFB2):​c.*747A>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.376 in 151,828 control chromosomes in the GnomAD database, including 11,651 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.38 ( 11651 hom., cov: 32)
Exomes 𝑓: 0.50 ( 0 hom. )

Consequence

TGFB2
NM_003238.6 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: 0.110
Variant links:
Genes affected
TGFB2 (HGNC:11768): (transforming growth factor beta 2) This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate a latency-associated peptide (LAP) and a mature peptide, and is found in either a latent form composed of a mature peptide homodimer, a LAP homodimer, and a latent TGF-beta binding protein, or in an active form consisting solely of the mature peptide homodimer. The mature peptide may also form heterodimers with other TGF-beta family members. Disruption of the TGF-beta/SMAD pathway has been implicated in a variety of human cancers. A chromosomal translocation that includes this gene is associated with Peters' anomaly, a congenital defect of the anterior chamber of the eye. Mutations in this gene may be associated with Loeys-Dietz syndrome. This gene encodes multiple isoforms that may undergo similar proteolytic processing. [provided by RefSeq, Aug 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.57).
BP6
Variant 1-218442109-A-C is Benign according to our data. Variant chr1-218442109-A-C is described in ClinVar as [Benign]. Clinvar id is 295502.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.698 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
TGFB2NM_003238.6 linkuse as main transcriptc.*747A>C 3_prime_UTR_variant 7/7 ENST00000366930.9
TGFB2NM_001135599.4 linkuse as main transcriptc.*747A>C 3_prime_UTR_variant 8/8
TGFB2NR_138148.2 linkuse as main transcriptn.3243A>C non_coding_transcript_exon_variant 7/7
TGFB2NR_138149.2 linkuse as main transcriptn.3327A>C non_coding_transcript_exon_variant 8/8

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
TGFB2ENST00000366930.9 linkuse as main transcriptc.*747A>C 3_prime_UTR_variant 7/71 NM_003238.6 P1P61812-1
TGFB2ENST00000366929.4 linkuse as main transcriptc.*747A>C 3_prime_UTR_variant 8/81 P61812-2
TGFB2ENST00000479322.1 linkuse as main transcriptn.1476A>C non_coding_transcript_exon_variant 5/53

Frequencies

GnomAD3 genomes
AF:
0.376
AC:
57031
AN:
151708
Hom.:
11628
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.467
Gnomad AMI
AF:
0.355
Gnomad AMR
AF:
0.473
Gnomad ASJ
AF:
0.324
Gnomad EAS
AF:
0.717
Gnomad SAS
AF:
0.373
Gnomad FIN
AF:
0.319
Gnomad MID
AF:
0.351
Gnomad NFE
AF:
0.285
Gnomad OTH
AF:
0.369
GnomAD4 exome
AF:
0.500
AC:
1
AN:
2
Hom.:
0
Cov.:
0
AF XY:
0.500
AC XY:
1
AN XY:
2
show subpopulations
GnomAD4 genome
AF:
0.376
AC:
57099
AN:
151826
Hom.:
11651
Cov.:
32
AF XY:
0.381
AC XY:
28285
AN XY:
74208
show subpopulations
Gnomad4 AFR
AF:
0.467
Gnomad4 AMR
AF:
0.474
Gnomad4 ASJ
AF:
0.324
Gnomad4 EAS
AF:
0.717
Gnomad4 SAS
AF:
0.371
Gnomad4 FIN
AF:
0.319
Gnomad4 NFE
AF:
0.285
Gnomad4 OTH
AF:
0.372
Alfa
AF:
0.350
Hom.:
1694
Bravo
AF:
0.395
Asia WGS
AF:
0.492
AC:
1714
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Loeys-Dietz syndrome 4 Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 27, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.57
CADD
Benign
13
DANN
Benign
0.89

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs991967; hg19: chr1-218615451; API